Insider Transactions in Q3 2023 at Amphastar Pharmaceuticals, Inc. (AMPH)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 06
2023
|
William J Peters CFO, EVP & TREASURER |
SELL
Open market or private sale
|
Direct |
60,743
-18.75%
|
$3,158,636
$52.0 P/Share
|
|
Sep 06
2023
|
William J Peters CFO, EVP & TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
56,500
+11.63%
|
$960,500
$17.68 P/Share
|
|
Aug 28
2023
|
Yakob Liawatidewi EVP CORP ADMIN CENTER |
SELL
Open market or private sale
|
Direct |
28,816
-29.26%
|
$1,527,248
$53.13 P/Share
|
|
Aug 28
2023
|
Yakob Liawatidewi EVP CORP ADMIN CENTER |
BUY
Exercise of conversion of derivative security
|
Direct |
28,816
+9.26%
|
$461,056
$16.74 P/Share
|
|
Aug 18
2023
|
Richard K Prins |
SELL
Open market or private sale
|
Direct |
2,000
-4.66%
|
$104,000
$52.5 P/Share
|
|
Aug 15
2023
|
Richard K Prins |
SELL
Open market or private sale
|
Direct |
4,163
-8.85%
|
$237,291
$57.39 P/Share
|
|
Aug 15
2023
|
Michael A Zasloff |
SELL
Open market or private sale
|
Direct |
12,759
-27.39%
|
$727,263
$57.22 P/Share
|